NYSCF CEO Susan L. Solomon Comments on Stem Cells and Regenerative Medicine

Recent advances in tissue engineering have changed the focus of regenerative medicine to addressing immediate challenges that stymie therapeutic application. Of note, an article Genetic Engineering and Biotechnology News focuses on bioprinting and bone and cartilage engineering. While both areas undergo refinement, stem cell production, per Susan L. Solomon, must be scaled up to meet the demand for cell therapy and drug development investigations.

Read the full article on Genetic Engineering and Biotechnology News >>